What does it take to turn scientific research into real therapeutic solutions?
It takes vision, collaboration and a strong commitment to excellence.
In this interview, Valentina Fiori, Biologics R&D Manager at Diatheva, shares her role in leading research projects focused on the development of therapeutic monoclonal antibodies for the treatment of cancer and infectious diseases.
Our biologics projects are built on long-standing collaborations with public and private research institutions, with one clear goal: transforming basic research into concrete applications that can make a difference in patients’ lives.
